Escalation in Antirheumatic Treatment, n | Month 6 | Month 12 | ||
---|---|---|---|---|
Flare, n = 8 5 (63%) | No Flare, n = 65 5 (8%) | Flare, n = 15 9 (60%) | No Flare, n = 62 4 (6%) | |
MTX* added or increased | 1 | 2 | 3 | 1 |
Non-MTX cDMARD added or increased | 2 | 2 | 2 | 2 |
MTX and non-MTX DMARD increased | 1 | 0 | 0 | 0 |
Glucocorticoids** added or increased | 0 | 1 | 2 | 0 |
bDMARD added or increased | 0 | 0 | 0 | 1 |
Physician intention to intensify but not initiated (e.g., declined by patient) | 1 | 0 | 2 | 0 |